KELLY CARMICHAEL: Open Payments
NPI 1669836979 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,485 in 25 payments from 19 companies in 2025. Trend: 2023 $1,082 · 2024 $680 · 2025 $2,485
Food & beverage: $2,485
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $257 |
| Amgen Inc. | 2 | $244 |
| Teva Pharmaceuticals USA, Inc. | 2 | $243 |
| Alnylam Pharmaceuticals Inc. | 1 | $141 |
| Boston Scientific Corporation | 1 | $134 |
| Axsome Therapeutics, Inc. | 2 | $128 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
Products named: AMVUTTRA, ULTOMIRIS, WATCHMAN FLX, Auvelity, VRAYLAR, BENLYSTA, EVENITY, Veozah.
Industry payments across MI — which companies pay providers there.
